Ovarian Cancer Diagnostics Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2018 - 2026
- Transparency Market Research
- In Vitro Diagnostics
Ovarian cancer is one of the most common types of cancer among women. It is a cancer that starts in the ovaries. Ovary is a female reproductive organ in which eggs or ova are developed. The female reproductive system comprises two ovaries: one on either side of the uterus. Ovaries produce hormones including progesterone and estrogen. Ovaries also produce ova (eggs). Ovarian cancer is only detectable after it spreads to the abdomen and pelvis. At this stage, the ovarian cancer is more fatal and challenging to treat. It can be treated more effectively in the initial stage when it is limited to the ovarian cells.
Chemotherapy and surgery are normally used in the treatment of ovarian cancer. In the initial stage, ovarian cancer infrequently causes various symptoms; however, in advanced stage of ovarian cancer, symptoms may nonspecific which are sometimes difficult to diagnose common benign conditions. There are several signs and symptoms for ovarian cancer including repeated need to urinate, variations in bowel habits such as constipation, uneasiness in the pelvis part, weight loss, rapidly feeling full when eating, and abdominal swelling or bloating.
Several factors can increase risk of ovarian cancer such as age when menstruation started and ended, estrogen hormone replacement therapy, family history of ovarian cancer, inherited gene mutations, and older age. Ovarian cancer is of three types based on the cells where cancer begins. These include epithelial tumor, stromal tumor, and germ cell tumor. According to research, around 90% of ovarian cancer is epithelial tumor and around 7% is stromal tumor. Germ cell tumor type ovarian cancer is rare and development of cancer starts from egg production cells.
Rise in incidence rate of ovarian cancer and increase in health awareness drive the global ovarian cancer diagnostics market. Moreover, increased government funding, surge in health care expenditure, and rise in aged women population propel the global market. However, lack of awareness about ovarian cancer and lack of accurate diagnosis are the major restraints of the global ovarian cancer diagnostics market.
The global ovarian cancer diagnostics market can be segmented based on cancer type, test type, end-user, and region. In terms of cancer type, the global market can be classified into epithelial tumor, germ cell tumor, and stromal tumor. Based on test type, the global ovarian cancer diagnostics market can be categorized into CA 125, HER 2, BRCA, CEA, ER & PR, KRAS mutation, and others. In terms of end-user, the global market can be divided into cancer research institutes, independent diagnostic laboratories, hospital associated labs, and others.
The global ovarian cancer diagnostics market can be segmented into five major regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is expected to dominate the global ovarian cancer diagnostics market due to availability of advanced diagnostic technology. Awareness among the people about the disease is also one of the major factors boosting the market in this region. The ovarian cancer diagnostics market in Asia Pacific is anticipated to expand at a rapid pace due to rise in prevalence of ovarian cancer. Lack of awareness about the disease and unavailability of advanced diagnostic procedures and treatment in underdeveloped countries such as Lebanon, Syria, Cyprus, Turkey, and Iraq are likely to propel the ovarian cancer diagnostics market in Middle East & Africa.
Major players operating in the global ovarian cancer diagnostics market include Abbott, F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific, Inc., AstraZeneca plc, and Bio-Rad Laboratories, Inc.
The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.
The study is a source of reliable data on:
- Market segments and sub-segments
- Market trends and dynamics
- Supply and demand
- Market size
- Current trends/opportunities/challenges
- Competitive landscape
- Technological breakthroughs
- Value chain and stakeholder analysis
The regional analysis covers:
- North America (U.S. and Canada)
- Latin America (Mexico, Brazil, Peru, Chile, and others)
- Western Europe (Germany, U.K., France, Spain, Italy, Nordic countries, Belgium, Netherlands, and Luxembourg)
- Eastern Europe (Poland and Russia)
- Asia Pacific (China, India, Japan, ASEAN, Australia, and New Zealand)
- Middle East and Africa (GCC, Southern Africa, and North Africa)
The report has been compiled through extensive primary research (through interviews, surveys, and observations of seasoned analysts) and secondary research (which entails reputable paid sources, trade journals, and industry body databases). The report also features a complete qualitative and quantitative assessment by analyzing data gathered from industry analysts and market participants across key points in the industry’s value chain.
A separate analysis of prevailing trends in the parent market, macro- and micro-economic indicators, and regulations and mandates is included under the purview of the study. By doing so, the report projects the attractiveness of each major segment over the forecast period.
Highlights of the report:
- A complete backdrop analysis, which includes an assessment of the parent market
- Important changes in market dynamics
- Market segmentation up to the second or third level
- Historical, current, and projected size of the market from the standpoint of both value and volume
- Reporting and evaluation of recent industry developments
- Market shares and strategies of key players
- Emerging niche segments and regional markets
- An objective assessment of the trajectory of the market
- Recommendations to companies for strengthening their foothold in the market
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.
Have query on this report?Make an Enquiry
The team was the biggest help to us. Not only were we provided with customized solutions but also we were guided through the most complicated situations. The information was on-point yet comprehensive. The experience was absolutely satisfying and helped us turn many challenges into opportunities.
Ours is a startup with a unique set of challenges and we were therefore hesitant but the team totally put us at ease with their knowledge and expertise. Our business and its challenges were understood perfectly and help was extended accordingly. The tailor made approach really helped us gain the most informative insights.
The report repository is absolutely impressive –updated and exhaustive in terms of markets covered and information provides. Besides, with the support extended to us by the team, we could reduce costs as well as move to sustainable growth. This really helped us tap into new opportunities. Happy to have gone ahead with ResearchMos.us.
We have had a long term engagement with ResearchMoz.us and never have we felt that the work done and help extended were below flawless. The report repository is one of the best one can hope to tap into. Recently, our partner businesses opted for consultancy services and they are all thrilled with the outcome.
Insights from reports helped us improve our profit margins significantly. Most of the knowledge we needed on the market were provided to us on a granular basis. From trends, and drivers to competitive analysis, the information was not just crisp but also insightful. That helped us chart a robust growth strategy and as of now we are happy to state that we are reaping big benefits.
More from In Vitro Diagnostics
Medical DevicesNebulizers-Medical Devices Pipeline Product Landscape, 2021